 |
PDBsum entry 2wzf
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Biochem J
426:281-292
(2010)
|
|
PubMed id:
|
|
|
|
|
| |
|
Molecular mechanism of elongation factor 1A inhibition by a Legionella pneumophila glycosyltransferase.
|
|
R.Hurtado-Guerrero,
T.Zusman,
S.Pathak,
A.F.Ibrahim,
S.Shepherd,
A.Prescott,
G.Segal,
D.M.van Aalten.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Legionnaires' disease is caused by a lethal colonization of alveolar macrophages
with the Gram-negative bacterium Legionella pneumophila. LpGT (L. pneumophila
glucosyltransferase; also known as Lgt1) has recently been identified as a
virulence factor, shutting down protein synthesis in the human cell by specific
glucosylation of EF1A (elongation factor 1A), using an unknown mode of substrate
recognition and a retaining mechanism for glycosyl transfer. We have determined
the crystal structure of LpGT in complex with substrates, revealing a GT-A fold
with two unusual protruding domains. Through structure-guided mutagenesis of
LpGT, several residues essential for binding of the UDP-glucose-donor and
EF1A-acceptor substrates were identified, which also affected L. pneumophila
virulence as demonstrated by microinjection studies. Together, these results
suggested that a positively charged EF1A loop binds to a negatively charged
conserved groove on the LpGT structure, and that two asparagine residues are
essential for catalysis. Furthermore, we showed that two further L. pneumophila
glycosyltransferases possessed the conserved UDP-glucose-binding sites and
EF1A-binding grooves, and are, like LpGT, translocated into the macrophage
through the Icm/Dot (intracellular multiplication/defect in organelle
trafficking) system.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |